Structure of Chemical Compounds, Methods of Analysis and Process Control Photostability Study in Pharmaceutical Development of a Solid Dosage Form of GML-3, A New Compound with Anxiolytic and Antidepressant Activity
Since the pronounced photosensitivity of the API GML-3, a compound with anxiolytic and antidepressant activity, has been previously shown, the aim of the present study was to select methods for protecting GML-3 in a solid dosage form (tablets) from exposure to light. The effect of electromagnetic ra...
Saved in:
Published in | Pharmaceutical chemistry journal Vol. 59; no. 4; pp. 491 - 499 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
New York
Springer US
01.07.2025
|
Subjects | |
Online Access | Get full text |
ISSN | 0091-150X 1573-9031 |
DOI | 10.1007/s11094-025-03420-1 |
Cover
Loading…
Abstract | Since the pronounced photosensitivity of the API GML-3, a compound with anxiolytic and antidepressant activity, has been previously shown, the aim of the present study was to select methods for protecting GML-3 in a solid dosage form (tablets) from exposure to light. The effect of electromagnetic radiation in the near ultraviolet and visible spectral ranges on the stability of GML-3 as part of a dosage form was studied in accordance with regulatory requirements under various conditions, e.g., in a model mixture with excipients, in a tablet mass, and as part of tablet cores and film-coated tablets. It was shown that GML-3 as part of tablets is also subject to photodegradation, but the excipients used in the production of GML-3 tablets do not cause or accelerate this process. Application of Opadry® II 85F18422 film coating made it possible to reduce the degree of GML-3 degradation, but its complete elimination under experimental conditions was achieved only when using primary and secondary packaging in the form of polypropylene jars placed in cardboard packs. |
---|---|
AbstractList | Since the pronounced photosensitivity of the API GML-3, a compound with anxiolytic and antidepressant activity, has been previously shown, the aim of the present study was to select methods for protecting GML-3 in a solid dosage form (tablets) from exposure to light. The effect of electromagnetic radiation in the near ultraviolet and visible spectral ranges on the stability of GML-3 as part of a dosage form was studied in accordance with regulatory requirements under various conditions, e.g., in a model mixture with excipients, in a tablet mass, and as part of tablet cores and film-coated tablets. It was shown that GML-3 as part of tablets is also subject to photodegradation, but the excipients used in the production of GML-3 tablets do not cause or accelerate this process. Application of Opadry® II 85F18422 film coating made it possible to reduce the degree of GML-3 degradation, but its complete elimination under experimental conditions was achieved only when using primary and secondary packaging in the form of polypropylene jars placed in cardboard packs. |
Author | Dorofeev, V. L. Sergeeva, M. S. Grushevskaya, L. N. Gaevaya, L. M. Markeev, V. B. |
Author_xml | – sequence: 1 givenname: L. N. surname: Grushevskaya fullname: Grushevskaya, L. N. email: grushevskaya_ln@academpharm.ru organization: Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies – sequence: 2 givenname: L. M. surname: Gaevaya fullname: Gaevaya, L. M. organization: Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies – sequence: 3 givenname: V. B. surname: Markeev fullname: Markeev, V. B. organization: Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies – sequence: 4 givenname: M. S. surname: Sergeeva fullname: Sergeeva, M. S. organization: Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies – sequence: 5 givenname: V. L. surname: Dorofeev fullname: Dorofeev, V. L. organization: Federal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies |
BookMark | eNp9kUFu2zAQRYkiBeqkvUBWPEDYDkVKspaC06QFnDaAE6A7gSZHMQOJNEgqqU7a65S2gy67GmBm_puP-efkzHmHhFxy-MwB6i-Rc2gkg6JkIGQBjL8jC17WgjUg-BlZADSc8RJ-fSDnMT4DZJkoFuTPJoVJpykg9T1d7XC0Wg105ce9n5yJV_QO086beBi3Tg1ztJEqZ-h98BpjzKsuBT_Q-51PPia1tYNNM92kyczUutxXYVQap3QkX-MLDn4_oksHpKIbP1hDr31UT0hvfBgP7du7NRNXtKU_8PWfGfpq0y6b-G39MGfa0UbrkjW4D9mKyshWJ_uS738k73s1RPz0Vi_I483Xh9U3tv55-33VrpkupExsK5cVaKNrWfVbbepeSm6qZckFNqCxqmrO9ZZLtexrXYKSQhd9JZEbWTRCKHFBihNXBx9jwL7bBzuqMHccukM03SmaLkfTHaPpeBaJkyjmZfeEoXv2U8jPjf9T_QXPwpef |
Cites_doi | 10.1016/S0378-5173(01)00746-3 |
ContentType | Journal Article |
Copyright | Springer Science+Business Media, LLC, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
Copyright_xml | – notice: Springer Science+Business Media, LLC, part of Springer Nature 2025 Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
DBID | AAYXX CITATION |
DOI | 10.1007/s11094-025-03420-1 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1573-9031 |
EndPage | 499 |
ExternalDocumentID | 10_1007_s11094_025_03420_1 |
GroupedDBID | --- -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 123 1N0 1SB 2.D 28- 29O 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 4.4 406 408 409 40D 40E 41~ 53G 5QI 5VS 642 67Z 6NX 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AACDK AAHNG AAIAL AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBBX ABBXA ABDBE ABDBF ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJNI ABJOX ABKCH ABKTR ABMNI ABMQK ABNWP ABQBU ABQSL ABRTQ ABSXP ABTEG ABTKH ABTMW ABULA ABWNU ABXPI ACAOD ACBXY ACDTI ACGFS ACHSB ACHXU ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACSNA ACSTC ACUDM ACUHS ACZOJ ADHHG ADHIR ADHKG ADIMF ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFIE AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFLOW AFOHR AFQWF AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHPBZ AHSBF AHWEU AHYZX AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AZFZN B-. BA0 BBWZM BDATZ BGNMA BSONS CAG COF CS3 CSCUP DDRTE DL5 DNIVK DPUIP EBD EBLON EBS EIOEI EJD ESBYG ESX FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ7 GQ8 GRRUI GXS H13 HF~ HG6 HMJXF HQYDN HRMNR HVGLF HZ~ IAO IHE IHR IJ- IKXTQ IWAJR IXC IXD IXE IZIGR IZQ I~X I~Z J-C JBSCW JCJTX JZLTJ KDC KOV KOW LAK LLZTM M4Y MA- MK0 N2Q NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P19 P9N PF0 PT4 PT5 QOK QOR QOS R4E R89 R9I RHV RIG RNI RNS ROL RPX RSV RZC RZE RZK S16 S1Z S26 S27 S28 S3B SAP SCLPG SCM SDE SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SZ9 SZN T13 T16 TEORI TSG TSK TSV TUC TUS U2A U9L UG4 UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 W4F WJK WK8 YLTOR ZGI ZMTXR ZOVNA ~8M ~A9 ~EX ~KM AAYXX CITATION |
ID | FETCH-LOGICAL-c244t-b4860cdc746fbcd7f441d68513e90ce66711cb14a8f7c50a43c2f64e1d42933a3 |
IEDL.DBID | U2A |
ISSN | 0091-150X |
IngestDate | Thu Aug 21 00:09:31 EDT 2025 Wed Aug 13 01:34:45 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | GML-3 packaging excipients tablets photostability film coating |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c244t-b4860cdc746fbcd7f441d68513e90ce66711cb14a8f7c50a43c2f64e1d42933a3 |
PageCount | 9 |
ParticipantIDs | crossref_primary_10_1007_s11094_025_03420_1 springer_journals_10_1007_s11094_025_03420_1 |
PublicationCentury | 2000 |
PublicationDate | 20250700 |
PublicationDateYYYYMMDD | 2025-07-01 |
PublicationDate_xml | – month: 7 year: 2025 text: 20250700 |
PublicationDecade | 2020 |
PublicationPlace | New York |
PublicationPlace_xml | – name: New York |
PublicationTitle | Pharmaceutical chemistry journal |
PublicationTitleAbbrev | Pharm Chem J |
PublicationYear | 2025 |
Publisher | Springer US |
Publisher_xml | – name: Springer US |
References | 3420_CR1 3420_CR2 LN Grushevskaya (3420_CR5) 2020; 54 3420_CR6 3420_CR3 VB Markeev (3420_CR4) 2024; 23 HH Tonnesen (3420_CR7) 2001; 225 |
References_xml | – ident: 3420_CR2 – volume: 23 start-page: 58 issue: 1 year: 2024 ident: 3420_CR4 publication-title: Ross. Bioterapevticheskii Zh. – ident: 3420_CR1 – ident: 3420_CR3 – ident: 3420_CR6 – volume: 225 start-page: 1 year: 2001 ident: 3420_CR7 publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(01)00746-3 – volume: 54 start-page: 40 issue: 8 year: 2020 ident: 3420_CR5 publication-title: Khim.-farm. Zh. |
SSID | ssj0010032 |
Score | 2.3443084 |
Snippet | Since the pronounced photosensitivity of the API GML-3, a compound with anxiolytic and antidepressant activity, has been previously shown, the aim of the... |
SourceID | crossref springer |
SourceType | Index Database Publisher |
StartPage | 491 |
SubjectTerms | Medicine Methods of Analysis and Process Control Organic Chemistry Pharmacology/Toxicology Pharmacy Structure of Chemical Compounds |
Title | Structure of Chemical Compounds, Methods of Analysis and Process Control Photostability Study in Pharmaceutical Development of a Solid Dosage Form of GML-3, A New Compound with Anxiolytic and Antidepressant Activity |
URI | https://link.springer.com/article/10.1007/s11094-025-03420-1 |
Volume | 59 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fS8MwEA6ioL6ITsWf4x7EFxdo2q5dHrvpFHUi6GA-lTRJYSCtuAn2L_Xf8ZKmTkEEn1ra9Bq4a_Kl-e47Qk64ygMpAk4z7kuK-B_Pol5INe-xMA-l4sKyfO-iq3F4PelOXFLYrGG7N1uSdqReJLsxz8jY-l1qZOs8imuela5Zu2MUj_3ka-8A47TWCOeMItyZuFSZ3238nI5-7oXaKWa4STYcNoSkduYWWdJFi6wNmpJsLbI6cjvhLXJ6X2tOVx14XKRQzTpwCvcLNepqm3w8WIXYt1cNZQ6NPgCYccBUVMInRraI9MzcbiRKQBQKXA4BDGo2O9ot5yWCSUunrcAwECuYFs373G9x-EZDMiYFPJTPUwXnpaGwwRAxsrl8ObqlQQcSwFH2qzNg_gpjJ96n5XOF1mw3kmI-dXxdjAJIZF3vYoeMhxePgyvqqjlQiRBiTjNT7koqGYdRnkkV5wjEVISAL9DckzqKYsZkxkLRy2PZ9UQYSD-PQs0UTplBIIJdslyUhd4joDn3IxlLbIOAU3kCcaBAJBijXcYF2ydnjVPTl1q0I13IM5sQSDEEUhsCKbbuNH5P3Qc8-6P5wf-aH5J138abYfgekWX0uT5GHDPP2mQlGfb7d-Z4-XRz0bZh_AmAAO-m |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Ra9swEBalg3YvZc1atm5r72HkZRFYtmNHjyZbmrZxKTSBvBlZksFQ7NGkUP_S_p2dZLleoAz2Zmz5LLiz9Nn33XeEfOeqCKQIOM25LynifzyKJiHVfMLCIpSKC8vyvY3mq_B6PV67orBNx3bvUpJ2pe6L3ZhnZGz9MTWydR7Fb553CAYmhsi18pPX3AHGaasRzhlFuLN2pTJv29jdjnZzoXaLmX0gRw4bQtI685js6WpADqddS7YBOUhdJnxAhnet5nQzgmVfQrUZwRDuejXq5iN5ubcKsU-PGuoCOn0AMOuA6aiEd6S2ifTGXO4kSkBUClwNAUxbNjvarbc1gklLp23AMBAbKKvuee63OPxFQzImBdzXD6WCn7WhsMEMMbI5fZkuaDCCBHCVfZ0MmL_COInnsn5o0JqdRlJtS8fXxSiARLb9Lk7IavZrOZ1T182BSoQQW5qbdldSyTiMilyquEAgpiIEfIHmntRRFDMmcxaKSRHLsSfCQPpFFGqmcMsMAhGckv2qrvQnAppzP5KxxDEIOJUnEAcKRIIx2mVcsM_kR-fU7Hcr2pH18swmBDIMgcyGQIajR53fM_cCb_4x_Oz_hl-Qw_kyXWSLq9ubL-S9b2PPsH2_kn30v_6GmGabn9sQ_gPuPO-J |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3fS8MwEA6ioL6ITsXf3oP44oJN27XLY9mcPycDHeytpEkKA2nFVbB_qf-Ol7TdFETwrbTpNXDX5Gvvu-8IOeMq9aTwOE24KynifzwKuj7VvMv81JeKC8vyfQxuxv7dpDP5VsVv2e5NSrKqaTAqTVlx-arSy0XhG3OMpK3boUbCzqH4_bOCyzEzcT12o3keAWO20gvnjCL0mdRlM7_b-Lk1_cyL2u1msEk2apwIUeXYLbKksxZZ6zXt2VpkdVhnxVvkfFTpT5dteF6UU83acA6jhTJ1uU0-n6xa7PubhjyFRisAzJpguivhHUPbUHpmLjdyJSAyBXU9AfQqZjvazYscgaWl1pZg2IglTLPmefUvcvhGSTImBTzlL1MF_dzQ2WCAeNmcvh4-UK8NEeCKO58MmD_EOImPaf5SojU7jSgrpjV3FyMCIln1vtgh48HVc--G1p0dqEQ4UdDEtL6SSoZ-kCZShSmCMhUg-PM0d6QOgpAxmTBfdNNQdhzhe9JNA18zhdun5wlvlyxneab3CGjO3UCGEscg-FSOQEwoEBWGaJdxwfbJRePU-LUS8IgXUs0mBGIMgdiGQIyj243f4_plnv0x_OB_w0_J6qg_iB9uH-8PybprQ88Qf4_IMrpfHyO8KZITG8FfjJ3zxQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Structure+of+Chemical+Compounds%2C+Methods+of+Analysis+and+Process+Control+Photostability+Study+in+Pharmaceutical+Development+of+a+Solid+Dosage+Form+of+GML-3%2C+A+New+Compound+with+Anxiolytic+and+Antidepressant+Activity&rft.jtitle=Pharmaceutical+chemistry+journal&rft.au=Grushevskaya%2C+L.+N.&rft.au=Gaevaya%2C+L.+M.&rft.au=Markeev%2C+V.+B.&rft.au=Sergeeva%2C+M.+S.&rft.date=2025-07-01&rft.pub=Springer+US&rft.issn=0091-150X&rft.eissn=1573-9031&rft.volume=59&rft.issue=4&rft.spage=491&rft.epage=499&rft_id=info:doi/10.1007%2Fs11094-025-03420-1&rft.externalDocID=10_1007_s11094_025_03420_1 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0091-150X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0091-150X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0091-150X&client=summon |